143 related articles for article (PubMed ID: 9255370)
1. [Systemic scleroderma and cancer. Search for predictive factors of cancer in 123 patients with scleroderma].
Kyndt X; Hebbar M; Queyrel V; Hachulla E; Hatron PY; Devulder B
Rev Med Interne; 1997 Jul; 18(7):528-32. PubMed ID: 9255370
[TBL] [Abstract][Full Text] [Related]
2. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract][Full Text] [Related]
3. [Influence of age on the clinical and biological characteristics of systemic scleroderma].
Kyndt X; Launay D; Hebbar M; Hatron PY; Fournier C; Michon-Pasturel U; Hachulla E; Devulder B
Rev Med Interne; 1999 Dec; 20(12):1088-92. PubMed ID: 10635070
[TBL] [Abstract][Full Text] [Related]
4. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
5. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antibodies in the relatives of patients with systemic sclerosis.
Takehara K; Moroi Y; Ishibashi Y
Br J Dermatol; 1985 Jan; 112(1):23-33. PubMed ID: 3918553
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis.
Igarashi A; Takehara K; Soma Y; Kikuchi K; Ishibashi Y
Dermatologica; 1990; 180(3):136-40. PubMed ID: 2340922
[TBL] [Abstract][Full Text] [Related]
8. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis (scleroderma) associated with discoid lupus erythematosus.
Sasaki T; Nakajima H
Dermatology; 1993; 187(3):178-81. PubMed ID: 8219419
[TBL] [Abstract][Full Text] [Related]
10. Antinuclear antibodies in progressive systemic sclerosis.
Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients].
Launay D; Hachulla E; Hatron PY; Michon-Pasturel U; Hebbar M; Queyrel V; Goullard L; Robin S; Rémy-Jardin M; Devulder B
Rev Med Interne; 2001 Sep; 22(9):819-29. PubMed ID: 11599184
[TBL] [Abstract][Full Text] [Related]
12. Anticentromere antibody in localized scleroderma.
Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
[TBL] [Abstract][Full Text] [Related]
13. Novel risk factors related to cancer in scleroderma.
Bernal-Bello D; de Tena JG; Guillén-Del Castillo A; Selva-O'Callaghan A; Callejas-Moraga EL; Marín-Sánchez AM; Fonollosa-Pla V; Simeón-Aznar CP
Autoimmun Rev; 2017 May; 16(5):461-468. PubMed ID: 28285170
[TBL] [Abstract][Full Text] [Related]
14. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.
Steen VD; Ziegler GL; Rodnan GP; Medsger TA
Arthritis Rheum; 1984 Feb; 27(2):125-31. PubMed ID: 6607734
[TBL] [Abstract][Full Text] [Related]
16. Anticentromere antibodies--clinical correlates.
Wade JP; Sack B; Schur PH
J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.
Steen VD; Powell DL; Medsger TA
Arthritis Rheum; 1988 Feb; 31(2):196-203. PubMed ID: 3348823
[TBL] [Abstract][Full Text] [Related]
18. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma).
Hietarinta M; Lassila O; Hietaharju A
Scand J Rheumatol; 1994; 23(2):64-7. PubMed ID: 8165439
[TBL] [Abstract][Full Text] [Related]
19. Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations.
Aeschlimann A; Meyer O; Bourgeois P; Haim T; Belmatoug N; Palazzo E; Kahn MF
Ann Rheum Dis; 1989 Dec; 48(12):992-7. PubMed ID: 2515813
[TBL] [Abstract][Full Text] [Related]
20. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
